1
|
Martino E, Bartalena L, Trimarchi F. A dwarf woman in the funeral procession of Hippolytus and Phaedra. J Endocrinol Invest 2024; 47:1311-1312. [PMID: 38055126 DOI: 10.1007/s40618-023-02244-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/06/2023] [Accepted: 11/09/2023] [Indexed: 12/07/2023]
Affiliation(s)
| | - L Bartalena
- School of Medicine, University of Insubria, Varese, Italy
| | - F Trimarchi
- Dipartimento di Medicina Clinica e Sperimentale, University of Messina, Messina, Italy.
| |
Collapse
|
2
|
Trimarchi F, Martino E. Acromegaly features in performing Marionette. J Endocrinol Invest 2022; 45:2407-2408. [PMID: 35737286 DOI: 10.1007/s40618-022-01834-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Accepted: 05/31/2022] [Indexed: 11/26/2022]
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti, Messina, Italy.
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
| | | |
Collapse
|
3
|
Toni R, Barbaro F, Di Conza G, Trimarchi F. Nodular goiter and laryngeal anatomic variant in two portraits of the hellenistic dramatist Menander. J Endocrinol Invest 2022; 45:2203-2204. [PMID: 35220560 DOI: 10.1007/s40618-022-01772-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/05/2022] [Accepted: 01/08/2022] [Indexed: 10/19/2022]
Affiliation(s)
- R Toni
- Department of Medicine and Surgery, Unit of Biomedical, Biotechnological and Translational Sciences, and Museum and Historical Library of Biomedicine - BIOMED, University of Parma, Parma, Italy.
- Division of Endocrinology, Diabetes, and Metabolism, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA.
| | - F Barbaro
- Department of Medicine and Surgery, Unit of Biomedical, Biotechnological and Translational Sciences, and Museum and Historical Library of Biomedicine - BIOMED, University of Parma, Parma, Italy
| | - G Di Conza
- Department of Medicine and Surgery, Unit of Biomedical, Biotechnological and Translational Sciences, and Museum and Historical Library of Biomedicine - BIOMED, University of Parma, Parma, Italy
| | - F Trimarchi
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| |
Collapse
|
4
|
Franchina T, Ficarra G, Fugazzotto D, Bitto A, Magaudda L, Trimarchi F, Di Mauro D, Zarzana M, Cacciola F, Aspria P, Franchina V, Adamo V. EP10.01-019 Rowing Against Cancer: From a Support Project to a Research Program. Perspectives and Challenges of Rowing in Metastatic Lung Cancer Patients. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.896] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
5
|
Martino E, Macrì L, Trimarchi F. Goiter in the models of Pre-Raphaelite Brotherhood. J Endocrinol Invest 2022; 45:1461-1462. [PMID: 34427898 DOI: 10.1007/s40618-021-01658-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Accepted: 07/29/2021] [Indexed: 10/20/2022]
Affiliation(s)
| | - L Macrì
- University of Pisa, Pisa, Italy
| | - F Trimarchi
- Accademia Peloritana dei Pericolanti, Messina, Italy
- Dipartimento di Medicina Clinica e Sperimentale, University of Messina, Messina, Italy
| |
Collapse
|
6
|
Tropea A, Tisano A, Bruschetta A, Borzelli D, Migliorato A, Nirta G, Leonardi G, Trimarchi F, Alito A. Comparative FE biomechanical and microbial adhesion analyses on an implanted humerus. J Orthop 2022; 32:78-84. [DOI: 10.1016/j.jor.2022.05.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Revised: 05/11/2022] [Accepted: 05/13/2022] [Indexed: 11/27/2022] Open
|
7
|
Affiliation(s)
- E Martino
- Universita degli Studi di Pisa, Pisa, Italy.
| | - L Macrì
- Universita degli Studi di Pisa, Pisa, Italy
| | | |
Collapse
|
8
|
Affiliation(s)
- A Gambineri
- Department of Medical and Surgical Science-DIMEC, Endocrinology Unit, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
| | - F Trimarchi
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
- Accademia Peloritana dei Pericolanti, Messina, Italy
| |
Collapse
|
9
|
Trimarchi F, Martino E. "The Salutation of Beatrice" by Dante Gabriel Rossetti: it was not Beatrice who had goiter but her model. J Endocrinol Invest 2021; 44:2857-2858. [PMID: 33978938 DOI: 10.1007/s40618-021-01588-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/29/2021] [Accepted: 04/30/2021] [Indexed: 10/21/2022]
Affiliation(s)
- F Trimarchi
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
| | | |
Collapse
|
10
|
Canale D, Martino E, Trimarchi F. The "Ensign Nun" Catalina de Erauso: a clinical endocrinology enigma. J Endocrinol Invest 2021; 44:2527-2528. [PMID: 33675532 DOI: 10.1007/s40618-021-01536-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/10/2021] [Accepted: 02/11/2021] [Indexed: 11/28/2022]
Affiliation(s)
- D Canale
- Unità di Endocrinologia 2, AOU Pisana, Pisa, Italy.
| | | | - F Trimarchi
- Dept of Medicina Clinica E Sperimentale, University of Messina, Messina, Italy
- Accademia Peloritana Dei Pericolanti at the University of Messina, Messina, Italy
| |
Collapse
|
11
|
Tanda ML, Trimarchi F. Graves' orbitopathy in Natalie Frank's oeuvre. J Endocrinol Invest 2021; 44:2533-2534. [PMID: 33786753 DOI: 10.1007/s40618-021-01564-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/22/2021] [Accepted: 03/26/2021] [Indexed: 11/29/2022]
Affiliation(s)
- M L Tanda
- Department of Medicine and Surgery, University of Insubria, Varese, Italy.
| | - F Trimarchi
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
- Accademia Peloritana dei Pericolanti, Messina, Italy
| |
Collapse
|
12
|
Abstract
Iodine deficiency is still the main cause of preventable thyroid disorders, worldwide. To optimize iodine intake, programs of voluntary or mandatory iodization of salt have been implemented in several iodine-deficient countries and iodine sufficiency has been achieved in many. Despite the clear beneficial effects on thyroid health, some concerns have been raised on the presumed detriment of iodine prophylaxis on thyroid autoimmunity. Very recent studies aimed at evaluating the long-term consequences of iodine supplementation on thyroid autoimmunity and related dysfunction, have clearly demonstrated that the early post-iodization increase in thyroid antibody positivity is largely transient and not clinically relevant, since the prevalence of overt thyroid dysfunction has remained reassuring low over two decades. The recommended iodine intake is therefore safe with regard to thyroid autoimmunity, the benefits largely outweighing the risks in a population with a stable median iodine concentration not exceeding 300 μg/L. Thus, a possible increase in thyroid autoimmunity should not represent a limitation to promoting iodine supplementation in the general population, also taking into account the steady rise in prevalence of autoimmune disorders which has occurred in the last few decades because of environmental factors other than iodine.
Collapse
Affiliation(s)
- R M Ruggeri
- Department of Clinical and Experimental Medicine, University of Messina, via Consolare Valeria, 1, 98125, Messina, Italy.
- Endocrine Unit At University Hospital "AOU Policlinico G.Martino", Messina, Italy.
| | - F Trimarchi
- Department of Clinical and Experimental Medicine, University of Messina, via Consolare Valeria, 1, 98125, Messina, Italy
- Accademia Peloritana Dei Pericolanti at the University of Messina, Messina, Italy
| |
Collapse
|
13
|
Trimarchi F, Martino E, Bartalena L. Comics' representation of Graves' orbitopathy, by Emil Ferris. J Endocrinol Invest 2021; 44:1799-1800. [PMID: 33389596 DOI: 10.1007/s40618-020-01469-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/11/2020] [Accepted: 11/15/2020] [Indexed: 10/22/2022]
Affiliation(s)
- F Trimarchi
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| | | | - L Bartalena
- Endocrine Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy
| |
Collapse
|
14
|
Affiliation(s)
- F Trimarchi
- Accademia Peloritana Dei Pericolanti at the University of Messina, Messina, Italy.
| | | | - L Bartalena
- Endocrine Unit, Department of Medicine and Surgery, University of Insubria, ASST Dei Sette Laghi, Varese, Italy
| |
Collapse
|
15
|
Trimarchi F, Martino E, Bartalena L. A young lady with goiter by Mario Sironi (1885-1961). J Endocrinol Invest 2021; 44:207-208. [PMID: 32596766 DOI: 10.1007/s40618-020-01345-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/15/2020] [Accepted: 06/23/2020] [Indexed: 10/24/2022]
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| | | | - L Bartalena
- Department of Medicine and Surgery, University of Insubria, Endocrine Unit, ASST dei Sette Laghi, Varese, Italy
| |
Collapse
|
16
|
Affiliation(s)
- A Olivieri
- Department of Cardiovascular and Endocrine-Metabolic Diseases and Aging, Italian National Institute of Health, Viale Regina Elena 299, 00162, Rome, Italy.
| | - F Trimarchi
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - P Vitti
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| |
Collapse
|
17
|
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| | | | - L Bartalena
- Endocrine Unit, Department of Medicine and Surgery, University of Insubria, ASST dei Sette Laghi, Varese, Italy
| |
Collapse
|
18
|
Ruggeri RM, Barbalace MC, Cristani MT, Alibrandi A, Giovinazzo S, Giuffrida G, Trimarchi F, Cannavò S, Campennì A. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis. J Endocrinol Invest 2020; 43:1337-1342. [PMID: 32232775 DOI: 10.1007/s40618-020-01231-7] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/08/2020] [Accepted: 03/17/2020] [Indexed: 12/17/2022]
Abstract
PURPOSE Advanced glycation end products (AGEs) are increased in conditions of oxidative stress and promote inflammation by interacting with their receptor RAGE on cell membrane. By contrast, the soluble receptor sRAGE exerts protective effects by competing with RAGE for ligand binding. AGEs/sRAGEs interaction is involved in the pathogenesis of several diseases related to oxidative stress. In the present study, we evaluated the AGEs/sRAGEs oxidative balance in Hashimoto' thyroiditis (HT). METHODS We measured the levels of sRAGE, by ELISA, and AGEs, by spectrophotometric method, in the serum of 50 HT patients (5 M, 45 F; mean age 38.5 ± 12 years) and 50 age-, sex- and BMI-matched healthy controls. All subjects were euthyroid at recruitment and none was on LT-4 therapy. RESULTS Serum sRAGEs were significantly lower (median 424 vs 738 pg/ml; p = 0.001) and AGEs higher (205 vs 114 AU/g prot; p = 0.001) in HT patients compared to controls, and the two parameters were inversely correlated (p = 0.016). Accordingly, the AGEs/sRAGEs ratio was threefold higher in HT patients than controls (0.48 vs 0.15; p = 0.0001). In regression analysis models, serum TPO-Ab were the main predictors for AGEs and sRAGEs levels and AGEs/sRAGEs ratio (p < 0.0001), irrespective of TSH and/or FT4 values. CONCLUSION sRAGEs were decreased and AGEs increased, suggesting a dysregulation of AGE/sRAGEs-related oxidative homeostasis in HT patients, even when in euthyroid status. Autoimmunity per se seems to play an important role in AGEs/sRAGE imbalance, irrespective of thyroid function alterations.
Collapse
Affiliation(s)
- R M Ruggeri
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
- Endocrine Unit, University Hospital AOU Policlinico G. Martino, 98125, Messina, Italy.
| | - M C Barbalace
- Department for Life Quality Studies, Alma Mater Studiorum, University of Bologna, Bologna, Italy
| | - M T Cristani
- Department of Pharmaceutical Sciences and Health Products, University of Messina, Messina, Italy
| | - A Alibrandi
- Unit of Statistical and Mathematical Sciences, Department of Economics, University of Messina, Messina, Italy
| | - S Giovinazzo
- Endocrine Unit, University Hospital AOU Policlinico G. Martino, 98125, Messina, Italy
| | - G Giuffrida
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
- Endocrine Unit, University Hospital AOU Policlinico G. Martino, 98125, Messina, Italy
| | - F Trimarchi
- Accademia Peloritana dei Pericolanti, University of Messina, Messina, Italy
| | - S Cannavò
- Endocrine Unit, University Hospital AOU Policlinico G. Martino, 98125, Messina, Italy
- Department of Human Pathology DETEV, University of Messina, Messina, Italy
| | - A Campennì
- Unit of Nuclear Medicine, Department of Biomedical Sciences and Morphological and Functional Images, University of Messina, Messina, Italy
| |
Collapse
|
19
|
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| | | | - L Bartalena
- Endocrine Unit, Department of Medicine & Surgery, University of Insubria, ASST dei Sette Laghi, Varese, Italy
| |
Collapse
|
20
|
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti, University of Messina, Messina, Italy.
| |
Collapse
|
21
|
Piantanida E, Ippolito S, Gallo D, Masiello E, Premoli P, Cusini C, Rosetti S, Sabatino J, Segato S, Trimarchi F, Bartalena L, Tanda ML. The interplay between thyroid and liver: implications for clinical practice. J Endocrinol Invest 2020; 43:885-899. [PMID: 32166702 DOI: 10.1007/s40618-020-01208-6] [Citation(s) in RCA: 53] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/22/2020] [Accepted: 02/27/2020] [Indexed: 02/07/2023]
Abstract
A complex relationship exists between thyroid and liver in health and disease. Liver plays an essential physiological role in thyroid hormone activation and inactivation, transport, and metabolism. Conversely, thyroid hormones affect activities of hepatocytes and hepatic metabolism. Serum liver enzyme abnormalities observed in hypothyroidism may be related to impaired lipid metabolism, hepatic steatosis or hypothyroidism-induced myopathy. Severe hypothyroidism may have biochemical and clinical features, such as hyperammonemia and ascites, mimicking those of liver failure. Liver function tests are frequently abnormal also in hyperthyroidism, due to oxidative stress, cholestasis, or enhanced osteoblastic activity. Antithyroid drug-associated hepatotoxicity is a rare event, likely related mainly to an idiosyncratic mechanism, ranging from a mild hepatocellular damage to liver failure. Propylthiouracil-induced liver damage is usually more severe than that caused by methimazole. On the other hand, thyroid abnormalities can be found in liver diseases, such as chronic hepatitis C, liver cirrhosis, hepatocellular carcinoma, and cholangiocarcinoma. In particular, autoimmune thyroid diseases are frequently found in patients with hepatitis C virus infection. These patients, especially if thyroid autoimmunity preexists, are at risk of hypothyroidism or, less frequently, thyrotoxicosis, during and after treatment with interpheron-alpha alone or in combination with ribavirin, commonly used before the introduction of new antiviral drugs. The present review summarizes both liver abnormalities related to thyroid disorders and their treatment, and thyroid abnormalities related to liver diseases and their treatment.
Collapse
Affiliation(s)
- E Piantanida
- Endocrine Unit, Department of Medicine and Surgery, Ospedale Di Circolo, ASST Dei Sette Laghi, University of Insubria, Viale Borri, 57, Varese, Italy.
| | - S Ippolito
- Endocrine Unit, Department of Medicine and Surgery, Ospedale Di Circolo, ASST Dei Sette Laghi, University of Insubria, Viale Borri, 57, Varese, Italy
| | - D Gallo
- Endocrine Unit, Department of Medicine and Surgery, Ospedale Di Circolo, ASST Dei Sette Laghi, University of Insubria, Viale Borri, 57, Varese, Italy
| | - E Masiello
- Endocrine Unit, Department of Medicine and Surgery, Ospedale Di Circolo, ASST Dei Sette Laghi, University of Insubria, Viale Borri, 57, Varese, Italy
| | - P Premoli
- Endocrine Unit, Department of Medicine and Surgery, Ospedale Di Circolo, ASST Dei Sette Laghi, University of Insubria, Viale Borri, 57, Varese, Italy
| | - C Cusini
- Endocrine Unit, Department of Medicine and Surgery, Ospedale Di Circolo, ASST Dei Sette Laghi, University of Insubria, Viale Borri, 57, Varese, Italy
| | - S Rosetti
- Endocrine Unit, Department of Medicine and Surgery, Ospedale Di Circolo, ASST Dei Sette Laghi, University of Insubria, Viale Borri, 57, Varese, Italy
| | - J Sabatino
- Endocrine Unit, Department of Medicine and Surgery, Ospedale Di Circolo, ASST Dei Sette Laghi, University of Insubria, Viale Borri, 57, Varese, Italy
| | - S Segato
- Gastroenterology and Gastrointestinal Endoscopic Unit, Department of Specialistic Medicine, ASST Dei Sette Laghi, Varese, Italy
| | - F Trimarchi
- Accademia Peloritana Dei Pericolanti, University of Messina, Messina, Italy
| | - L Bartalena
- Endocrine Unit, Department of Medicine and Surgery, Ospedale Di Circolo, ASST Dei Sette Laghi, University of Insubria, Viale Borri, 57, Varese, Italy.
| | - M L Tanda
- Endocrine Unit, Department of Medicine and Surgery, Ospedale Di Circolo, ASST Dei Sette Laghi, University of Insubria, Viale Borri, 57, Varese, Italy
| |
Collapse
|
22
|
Trimarchi F, Martino E, Bartalena L. Cushing syndrome at the court of the infant of Spain in the eighteenth century? J Endocrinol Invest 2020; 43:871-872. [PMID: 31927746 DOI: 10.1007/s40618-020-01181-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/31/2019] [Accepted: 01/06/2020] [Indexed: 10/25/2022]
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| | | | - L Bartalena
- Endocrine Unit, Department of Medicine and Surgery, ASST dei Sette Laghi, University of Insubria, Varese, Italy
| |
Collapse
|
23
|
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| | | | - L Bartalena
- Endocrine Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy
| |
Collapse
|
24
|
Trimarchi F, Martino E, Bartalena L. The multinodular goiter of the virtuous Roman matron Lucretia by Artemisia Gentileschi. J Endocrinol Invest 2020; 43:701-702. [PMID: 31786793 DOI: 10.1007/s40618-019-01157-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/23/2019] [Accepted: 11/27/2019] [Indexed: 11/24/2022]
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at The University of Messina, Messina, Italy.
| | | | - L Bartalena
- Endocrine Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy
| |
Collapse
|
25
|
Trimarchi F, Martino E, Bartalena L. Pituitary disorders as wonders and curiosity in XVI Century. J Endocrinol Invest 2020; 43:551-552. [PMID: 31541407 DOI: 10.1007/s40618-019-01121-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/14/2019] [Accepted: 09/17/2019] [Indexed: 11/26/2022]
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti, University of Messina, Messina, Italy.
| | | | - L Bartalena
- Endocrine Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy
| |
Collapse
|
26
|
Affiliation(s)
- R Dionigi
- University of Insubria, Varese, Italy
| | - F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy
| | - G Dionigi
- Division for Endocrine and Minimally Invasive Surgery, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University Hospital G. Martino, University of Messina, Via C. Valeria 1, 98125, Messina, Italy.
| |
Collapse
|
27
|
Giuffrida G, Bagnato G, Campennì A, Giovinazzo S, Keller KP, Alibrandi A, Roberts WN, Trimarchi F, Ruggeri RM. Non-specific rheumatic manifestations in patients with Hashimoto's thyroiditis: a pilot cross-sectional study. J Endocrinol Invest 2020; 43:87-94. [PMID: 31301020 DOI: 10.1007/s40618-019-01083-w] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/22/2019] [Accepted: 07/08/2019] [Indexed: 02/07/2023]
Abstract
PURPOSE Hashimoto's thyroiditis (HT) is often associated with rheumatic disorders (arthritis, etc.), but many HT patients report non-specific rheumatic signs and symptoms in the absence of clinically evident rheumatic diseases. Aim of this study was to evaluate the prevalence of non-specific rheumatic manifestations (RMs) in HT subjects without classified autoimmune comorbidities. METHODS 500 HT patients (467 F, 33 M; median age 41 years, range 14-69) and 310 age- and sex-matched controls, consecutively referred to the Endocrine Unit of Messina University Hospital, were evaluated for non-specific RMs. None took L-thyroxine. EXCLUSION CRITERIA autoimmune comorbidities, infectious, and/or inflammatory diseases, history of neoplasia, BMI > 30 kg/m2. RESULTS In our HT cohort, 100 patients (20%) complained of one or more RMs, vs 21 controls (6.8%; P < 0.001). There were minimal differences between the manifestations recorded in the two groups, the most common being polyarthralgias and myalgias/fibromyalgia, but non-specific RMs occurred threefold more in HT patients. Comparing HT patients with RMs (96 F and 4 M) with those affected by HT alone, female sex was prevalent (F:M ratio 24:1 vs 5:1) with higher age at diagnosis (median 43 vs 37 years; P < 0.001). HT patients with RMs (62%) were mostly euthyroid (median TSH 2.0 µIU/L) and only 7% overtly hypothyroid, discouraging a possible causal relationship between thyroid dysfunction per se and RMs. CONCLUSIONS A significant percentage of HT patients complains of non-specific rheumatic signs and symptoms, in the absence of other diagnosed systemic comorbidities and regardless of thyroid functional status, deserving careful evaluation and prolonged follow-up.
Collapse
Affiliation(s)
- G Giuffrida
- Unit of Endocrinology, Department of Clinical and Experimental Medicine, Gaetano Martino University Hospital, University of Messina, Via Consolare Valeria 1, 98125, Messina, Italy.
- Endocrine Unit at University Hospital of Messina, Messina, Italy.
| | - G Bagnato
- NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK
| | - A Campennì
- Unit of Nuclear Medicine, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy
| | - S Giovinazzo
- Endocrine Unit at University Hospital of Messina, Messina, Italy
| | - K P Keller
- Unit of Rheumatology, Division of Medicine, University of Kentucky, Lexington, KY, USA
| | - A Alibrandi
- Department of Economics, Unit of Statistical and Mathematical Sciences, University of Messina, Messina, Italy
| | - W N Roberts
- Unit of Rheumatology, Division of Medicine, University of Kentucky, Lexington, KY, USA
| | - F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy
| | - R M Ruggeri
- Unit of Endocrinology, Department of Clinical and Experimental Medicine, Gaetano Martino University Hospital, University of Messina, Via Consolare Valeria 1, 98125, Messina, Italy
- Endocrine Unit at University Hospital of Messina, Messina, Italy
| |
Collapse
|
28
|
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| | | | - L Bartalena
- Endocrine Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy
| |
Collapse
|
29
|
Trimarchi F, Martino E, Bartalena L. The clinical enigma of the "Flea catcher" by Georges de La Tour: a pregnant sinner with pre-eclampsia or a hypothyroid girl? J Endocrinol Invest 2019; 42:995-996. [PMID: 30730039 DOI: 10.1007/s40618-019-01017-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/25/2019] [Accepted: 02/04/2019] [Indexed: 11/27/2022]
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| | | | - L Bartalena
- Endocrine Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy
| |
Collapse
|
30
|
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti, University of Messina, Messina, Italy.
| |
Collapse
|
31
|
Ruggeri RM, Campennì A, Giuffrida G, Trimboli P, Giovanella L, Trimarchi F, Cannavò S. Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know). J Endocrinol Invest 2019; 42:745-756. [PMID: 30471004 DOI: 10.1007/s40618-018-0984-z] [Citation(s) in RCA: 41] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/01/2018] [Accepted: 11/15/2018] [Indexed: 12/26/2022]
Abstract
Immune checkpoint inhibitors (ICIs) are novel anticancer agents, recently introduced with the aim of boosting the immune response against tumors. ICIs are monoclonal autoantibodies that specifically target inhibitory receptors on T cells: cytotoxic T lymphocyte antigen 4 (CTLA4), programmed death 1 (PD-1) and its ligand (PD-1L). ICIs also generate peculiar dysimmune toxicities, called immune-related adverse events (irAEs), that can potentially affect any tissue, and some may be life-threatening if not promptly recognized. The endocrine and metabolic side effects of ICIs are reviewed here, with a particular focus on their clinical presentation and management. They are among the most frequent toxicities (around 10%) and include hypophysitis, thyroid disorders, adrenalitis, and diabetes mellitus. Treatment is based on the replacement of specific hormone deficits, accompanied by immunosuppression (with corticosteroids or other drugs), depending on irAEs grade, often without the need of ICI withdrawal, except in more severe forms. Prompt recognition of endocrine and metabolic irAEs and adequate treatment allow the patients to continue a therapy they are benefiting from. Endocrinologists, as an integral part of the multidisciplinary oncologic team, need to be familiar with the unique toxicity profile of these anticancer agents. Practical recommendations for their management are proposed.
Collapse
Affiliation(s)
- R M Ruggeri
- Unit of Endocrinology, Department of Clinical and Experimental Medicine, Building H, Floor 4, "G. Martino" University Hospital, University of Messina, 98125, Messina, Italy
| | - A Campennì
- Unit of Nuclear Medicine, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, Messina, Italy
| | - G Giuffrida
- Unit of Endocrinology, Department of Clinical and Experimental Medicine, Building H, Floor 4, "G. Martino" University Hospital, University of Messina, 98125, Messina, Italy.
| | - P Trimboli
- Nuclear Medicine, PET/CT Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
| | - L Giovanella
- Nuclear Medicine, PET/CT Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
| | - F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy
| | - S Cannavò
- Department of Human Pathology of Adulthood and Childhood "Gaetano Barresi", University of Messina, Messina, Italy
| |
Collapse
|
32
|
Trimarchi F, Cucinotta D. The Mediterranean diet of an Italian worker of the sixteenth century portrayed by Annibale Carracci (1560-1609). J Endocrinol Invest 2019; 42:743-744. [PMID: 30618029 DOI: 10.1007/s40618-019-1003-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/28/2018] [Accepted: 01/04/2019] [Indexed: 02/01/2023]
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti, University of Messina, Messina, Italy.
| | - D Cucinotta
- Dipartimento di Medicina Clinica e Sperimentale, University of Messina, Messina, Italy
| |
Collapse
|
33
|
Trimarchi F, Jannini EA. A Flemish Kermis by Peeter Baltens: fashion or Peyronie's disease? J Endocrinol Invest 2019; 42:491-493. [PMID: 30094744 DOI: 10.1007/s40618-018-0933-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/20/2018] [Accepted: 08/01/2018] [Indexed: 10/28/2022]
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| | - E A Jannini
- Department of Systems Medicine, University of Rome Tor Vergata Rome, Rome, Italy
| |
Collapse
|
34
|
Ruggeri RM, Cristani M, Vicchio TM, Alibrandi A, Giovinazzo S, Saija A, Campennì A, Trimarchi F, Gangemi S. Increased serum interleukin-37 (IL-37) levels correlate with oxidative stress parameters in Hashimoto's thyroiditis. J Endocrinol Invest 2019; 42:199-205. [PMID: 29796799 DOI: 10.1007/s40618-018-0903-3] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/27/2018] [Accepted: 05/14/2018] [Indexed: 12/12/2022]
Abstract
PURPOSE Interleukin-37 (IL-37), member of the IL-1 family, is a natural suppressor of immune and inflammatory responses. Increased serum IL-37 levels were observed in several autoimmune diseases, including Graves' disease. To our knowledge, no data on Hashimoto's thyroiditis (HT) are available in the literature. METHODS Aim of our study was to measure serum IL-37 levels and evaluate their relationship, if any, with oxidative stress markers in HT patients. We enrolled 45 euthyroid HT patients (5 M e 40 F, median age 40 years) and 50 age- and sex-matched healthy controls. None was under L-thyroxine therapy. Serum IL-37 levels were measured by ELISA. Specific serum tests, such as derived reactive oxygen metabolites (d-ROMs), and biological anti-oxidant potential (BAP) test were performed in all subjects to investigate the changes in oxidative balance, and advanced glycation end products (AGEs) were determined as a specific marker of oxidative stress. RESULTS IL-37 levels were significantly higher in HT than in controls (median 475 vs. 268 pg/ml, P = 0.018). In the same patients, serum oxidants (d-ROMs) were increased and anti-oxidants (BAP) decreased compared with controls (P = 0.011 and < 0.0001, respectively), clearly indicating an enhanced oxidative stress. In addition, AGEs levels were higher in HT patients than in controls (210 vs. 140 AU/g prot, P < 0.0001) and directly correlated with IL-37 levels (P = 0.048). At multivariate analysis, the main independent predictors that influenced IL-37 levels were both anti-thyroid antibodies (P = 0.026) and AGEs levels (P = 0.001). CONCLUSIONS IL-37 is up-regulated in HT and may exert a protective role by counteracting oxidative stress and inflammation.
Collapse
Affiliation(s)
- R M Ruggeri
- Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
- UOC di Endocrinologia, Dipartimento di Medicina Clinica e Sperimentale, Padiglione H, 4 piano - Policlinico Universitario "G. Martino", 98125, Messina, Italy.
| | - M Cristani
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy
| | - T M Vicchio
- Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - A Alibrandi
- Unit of Statistical and Mathematical Sciences, Department of Economics, University of Messina, Messina, Italy
| | - S Giovinazzo
- Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - A Saija
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy
| | - A Campennì
- Unit of Nuclear Medicine, Department of Biomedical and Dental Sciences, and Morpho-Functional Images, University of Messina, Messina, Italy
| | - F Trimarchi
- Accademia Peloritana dei Pericolanti, University of Messina, Messina, Italy
| | - S Gangemi
- Department of Clinical and Experimental Medicine, Postgraduate School and Division of Allergy and Clinical Immunology, University of Messina, Messina, Italy
| |
Collapse
|
35
|
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| |
Collapse
|
36
|
Campennì A, Trimarchi F, Baldari S. Comment on: Lack of association between obesity and aggressiveness of differentiated thyroid cancer. J Endocrinol Invest 2019; 42:107-108. [PMID: 30343357 DOI: 10.1007/s40618-018-0970-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/12/2018] [Accepted: 10/19/2018] [Indexed: 12/16/2022]
Affiliation(s)
- A Campennì
- Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, 98125, Messina, Italy.
| | - F Trimarchi
- Accademia Peloritana dei Pericolanti, University of Messina, Messina, Italy
| | - S Baldari
- Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, 98125, Messina, Italy
| |
Collapse
|
37
|
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| |
Collapse
|
38
|
Campennì A, Ruggeri RM, Siracusa M, Pignata SA, Di Mauro F, Vento A, Trimarchi F, Baldari S. Combined BRAF V600E analysis and 99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation. J Endocrinol Invest 2018; 41:1283-1288. [PMID: 29549631 DOI: 10.1007/s40618-018-0864-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/08/2018] [Accepted: 03/07/2018] [Indexed: 01/05/2023]
Abstract
PURPOSE The aim of the present study was to evaluate the possible diagnostic role of the combined performance of BRAF mutation analysis and MIBI scintigraphy in papillary thyroid cancer (PTC) patients with incomplete bio-chemical response to first radioiodine therapy (RAIT) performed for thyroid remnant ablation. METHODS The records of 15 PTC patients with bio-chemical incomplete response to first RAIT were retrospectively analyzed. BRAFV600E analysis on primary tumor samples was obtained in all cases along with neck ultrasonography and 99mTc-MIBI scintigraphy of the neck-thorax regions at first follow-up. All patients then underwent RAIT with high radioiodine activities. A post-therapy whole-body scan (pT-WBS) was acquired 5-7 days after RAIT. RESULTS Abnormal radioiodine uptake was found in 10 out of the 15 patients (67%, 131I+ve), while in the remaining 33%, no abnormal radioiodine uptake was detected (5/15, 131I-ve). Abnormal tracer uptake was found in 6 out of 10 131I+ve patients at 99mTc-MIBI scintigraphy (MIBI+ve). BRAFV600E mutation was not found in the majority of 131I+ve patients (9 out of 10 BRAFV600E-ve). On the contrary, in the 5 131I-ve patients, 99mTc-MIBI scintigraphy did not show any abnormal tracer uptake (MIBI-ve), while BRAFV600E mutation was present (BRAFV600E+ve). Thus, in our series, the association between MIBI-ve scintigraphy and BRAF+ve mutation was a useful diagnostic tool in predicting negative pT-WBS outcome. CONCLUSION Albeit obtained in a small retrospective series, our results suggest that the combination of BRAFV600E+ve mutation and MIBI-ve scintigraphy may be considered a negative prognostic clue, which predicts the absence of radioiodine uptake at pT-WBS in DTC patients with incomplete bio-chemical response to first RAIT.
Collapse
Affiliation(s)
- A Campennì
- Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Nuclear Medicine Unit, University of Messina, Messina, Italy.
| | - R M Ruggeri
- Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Messina, Messina, Italy
| | - M Siracusa
- Dipartimento Servizi Diagnostici, UOC di Medicina Nucleare-ARNAS Civico Di Cristina Benfratelli, Palermo, Italy
| | - S A Pignata
- Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Nuclear Medicine Unit, University of Messina, Messina, Italy
| | - F Di Mauro
- Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Nuclear Medicine Unit, University of Messina, Messina, Italy
| | - A Vento
- Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Nuclear Medicine Unit, University of Messina, Messina, Italy
| | - F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy
| | - S Baldari
- Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Nuclear Medicine Unit, University of Messina, Messina, Italy
| |
Collapse
|
39
|
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| |
Collapse
|
40
|
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| |
Collapse
|
41
|
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| | - F De Luca
- Dipartimento di Patologia Umana dell'adulto e dell'età evolutiva Gaetano Barresi, University of Messina, Messina, Italy
| |
Collapse
|
42
|
Trimarchi F, Vitti P. Gabriella Morreale de Escobar (1930-2017). J Endocrinol Invest 2018; 41:497. [PMID: 29582343 DOI: 10.1007/s40618-018-0878-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/19/2018] [Accepted: 03/20/2018] [Indexed: 10/17/2022]
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| | - P Vitti
- Unit of Endocrinology, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Pisa, Italy
| |
Collapse
|
43
|
Bianchi PE, Salati R, Guagliano R, Traselli GP, Rondini G, Trimarchi F. Review of Experience with Retinopathy of Prematurity from the Pavia Registry (1990-1993). Eur J Ophthalmol 2018; 6:187-91. [PMID: 8823595 DOI: 10.1177/112067219600600217] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
In this retrospective study we analysed the prevalence of retino-pathy of prematurity (ROP) and its sequelae in a sample of premature infants with birth weight less than 1500 grams. From 1 January 1990 to 31 October 1993, we studied 160 surviving premature infants with very low birth weight (< 1.500 g) referred to the Neonatal Intensive Care Unit of the I.R.C.C.S. Policlinico San Matteo, Pavia, Italy. Thirty percent of these infants suffered from ROP, and 13.7%, with severe ROP, underwent cryotherapy. These latter had very-very low birth weight (< 1.000 g) and low gestational age (< 28 weeks). Follow-up of 69 infants at 12 months for retinal sequelae, refraction defects, bin-ocular vision and ocular motility impairments gave the following results: 1) strabismus 20.3%; 2) > 3D hyperopia 3%; 3) myopia 30.4%; 4) > 5D myopia 3.7%. The incidence of refraction and ocular motility anomalies in patients with acute ROP with spontaneous remission was similar to that of unaffected premature infants. Conversely, in the patients treated with cryotherapy the incidence of strabismus and > 5D myopia was greater than for untreated infants: 30% vs 15.4% (n.s.) and 14.7% vs 0% (p = 0.05), respectively. Cryotherapy was successful in 91.9% of cases and in 37.8% of cases the cicatricial sequelae were limited to peripheral chorioretinal scars.
Collapse
Affiliation(s)
- P E Bianchi
- Department of Ophthalmology, University of Pavia, Italy
| | | | | | | | | | | |
Collapse
|
44
|
Bianchi PE, Guagliano R, Salati R, Traselli GP, Trimarchi F. Esotropia and Pseudoexotropia in Acute Rop Sequelae: Clinical Features and Suggestions for Treatment. Eur J Ophthalmol 2018; 6:446-50. [PMID: 8997590 DOI: 10.1177/112067219600600418] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
We report five cases with a mixture of esotropia and pseudoexotropia due to macular ectopia related cicatricial retinopathy of prematurity (ROP). On inspection, the patients, aged from 9 to 28 years, presented a divergence of the eyes and a nasally decentralised corneal light reflex. The cover test showed esodeviation. All the cases presented some clinical features common to congenital strabismus. Fundus examination showed temporal traction of vascular and retinal tissues and macular ectopia, referrable to cicatricial sequelae of spontaneously regressed severe ROP. Treatment is limited to follow-up, with attention being paid to the control of retinal damage rather than to resolving the esthetic defects. Despite cryotherapy, these conditions are increasing with the increase in severe ROP and are now relatively frequent. We suggest that they be carefully identified in order to avoid incorrect orthoptic or surgical treatment.
Collapse
Affiliation(s)
- P E Bianchi
- Eye Clinic, University of Pavia, IRCCS San Matteo Hospital, Italy
| | | | | | | | | |
Collapse
|
45
|
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| | - S Cannavò
- Dipartimento di Patologia Umana dell'adulto e dell'età evolutiva Gaetano Barresi, University of Messina, Messina, Italy
| |
Collapse
|
46
|
Trimarchi F, De Luca F. A congenitally hypothyroid young man (Seated Dwarf, Goya's Studio, 19th century). J Endocrinol Invest 2018; 41:381-382. [PMID: 29349643 DOI: 10.1007/s40618-018-0834-z] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/05/2018] [Accepted: 01/12/2018] [Indexed: 10/18/2022]
Affiliation(s)
- F Trimarchi
- Accademia Peloritana dei Pericolanti at the University of Messina, Messina, Italy.
| | - F De Luca
- Dipartimento di Patologia Umana dell'adulto e dell'età evolutiva Gaetano Barresi, University of Messina, Messina, Italy
| |
Collapse
|
47
|
Affiliation(s)
- G Borzì
- Endocrinology, Garibaldi-Nesima Hospital, Via Palermo 636, 95122, Catania, Italy
| | - F Trimarchi
- Accademia Peloritana dei Pericolanti, Piazza Pugliatti 1, 98122, Messina, Italy
| | - M Russo
- Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria 1, 98125, Messina, Italy.
| |
Collapse
|
48
|
Kernt K, Martinez M, Bertin D, Stroman D, Cupp G, Martinez C, Tirado M, Guasch J, Kernt K, Lizin F, Cano J, Wesner M, Alemany P, Jungmann P, Partouche P, Sitruk A, Christmann T, Kandarakis A, Royo M, Arias A, Bacquaert J, Dua H, Tomazzoli L, Forsman E, Gerstenberger A, Bertel F, Bouzas E, Trimarchi F, Kaye S, Orsoni G, Klauss V, Mandel S, Mortemousque B. A Clinical Comparison of Two Formulations of Tobramycin 0.3% Eyedrops in the Treatment of Acute Bacterial Conjunctivitis. Eur J Ophthalmol 2018. [DOI: 10.1177/112067210501500504] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Purpose To compare the safety and efficacy of a new enhanced viscosity ophthalmic formulation of tobramycin, given twice daily (BID), with the existing four times daily (QID) treatment regimen in patients with acute bacterial conjunctivitis. Methods This was a 12-day, multicenter, observer-masked, randomized, parallel group study. Patients received one drop of tobramycin 0.3% (3 mg/mL) enhanced viscosity ophthalmic solution BID or tobramycin 0.3% (3 mg/mL) ophthalmic solution QID in the affected eyes for 7 days. The primary efficacy variable was the percentage of patients with sustained cure/presumed bacterial eradication based on clinical judgment at the test-of-cure visit (Day 12). Pretherapy bacterial isolates were obtained and tested for susceptibility to tobramycin by determination of minimum inhibitory concentrations (MIC). Results A total of 276 patients were enrolled in the study and 203 of these were culture positive and attended all follow-up examinations. In this group, 98% of those treated with tobramycin enhanced viscosity ophthalmic solution and 99% of those treated with tobramycin 0.3% ophthalmic solution were categorized as having sustained cure/presumed eradication at the test-of-cure visit (p=0.6037). Reported adverse events were not serious, mild to moderate in severity, and generally did not prevent continuation in the study. Several pretreatment pathogens demonstrated tobramycin resistance (MIC > 4 mg/mL). However, therapy with both treatments was effective in the majority of the cases. Conclusions Tobramycin enhanced viscosity ophthalmic solution is well tolerated and has equivalent efficacy to the established treatment regimen with a simplified posology. The formulation provides an alternative therapy for acute bacterial conjunctivitis that should improve patient compliance and satisfaction.
Collapse
Affiliation(s)
- K. Kernt
- Augenärztpraxis, Muenchen, Germany
| | - M. Martinez
- R&D Clinical Sciences AlconCusí, Barcelona - Spain
| | - D. Bertin
- R&D Clinical Sciences, Milano - Italy
| | - D. Stroman
- R&D Microbiology, Alcon Research, Ltd., Fort Worth, Texas - USA
| | - G. Cupp
- R&D Microbiology, Alcon Research, Ltd., Fort Worth, Texas - USA
| | - C. Martinez
- R&D Clinical Sciences AlconCusí, Barcelona - Spain
| | - M. Tirado
- R&D Clinical Sciences AlconCusí, Barcelona - Spain
| | - J. Guasch
- R&D Clinical Sciences AlconCusí, Barcelona - Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | - H. Dua
- Nottingham, United Kingdom
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Cannavo S, Trimarchi F, Ferraù F. Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden. Mol Cell Endocrinol 2017; 457:81-88. [PMID: 27998805 DOI: 10.1016/j.mce.2016.12.019] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/17/2016] [Revised: 12/15/2016] [Accepted: 12/16/2016] [Indexed: 12/13/2022]
Abstract
Increasing evidence suggests that environmental contaminants can exert endocrine disruptors activities and that pollution exposition can have a role in tumorigenic processes. Several environmental pollutants have been shown to affect pituitary cells biology and function. The aryl hydrocarbon receptor (AHR) pathway is involved in xenobiotics' metabolism and in tumorigenesis. A deregulation of the AHR pathway could have a role in pituitary tumours' pathophysiology, especially in the GH secreting ones. AHR-interacting protein (AIP) is one of the key partners of AHR and is implicated in pituitary tumours' pathogenesis. Moreover, an increased prevalence of acromegaly has been reported in a highly polluted area of the province of Messina (Sicily, Italy). Nevertheless, at present, few data are available about the potential role of environmental factors in the pathogenesis and clinical expression of GH secreting pituitary tumours. This review is aimed at discussing the evidences on the potential links among environmental pollutants, the AHR pathway and the pathophysiology of GH-secreting pituitary adenomas.
Collapse
Affiliation(s)
- S Cannavo
- Department of Clinical and Experimental Medicine - Endocrinology Unit, University of Messina, Italy
| | - F Trimarchi
- Department of Clinical and Experimental Medicine - Endocrinology Unit, University of Messina, Italy
| | - F Ferraù
- Department of Clinical and Experimental Medicine - Endocrinology Unit, University of Messina, Italy.
| |
Collapse
|
50
|
Giovinazzo S, Alibrandi A, Campennì A, Trimarchi F, Ruggeri RM. Correlation of cardio-metabolic parameters with vitamin D status in healthy premenopausal women. J Endocrinol Invest 2017; 40:1337-1343. [PMID: 28616825 DOI: 10.1007/s40618-017-0707-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/31/2017] [Accepted: 05/30/2017] [Indexed: 12/27/2022]
Abstract
PURPOSE Vitamin D has been associated with metabolic disorders and increasing risk of cardiovascular diseases, with conflicting results. Aim of our study was to evaluate the relationship, if any, between cardio-metabolic risk factors and serum 25(OH)D concentrations in healthy women in premenopausal age. METHODS We enrolled 200 healthy women, aged 19-50 years (mean age ± SD, 38 ± 11 years). In each subject, we measured serum 25(OH)D in relation to metabolic biomarkers and cardiovascular parameters. RESULTS A status of vitamin D deficiency was found in 48% of the study population, while 38% showed levels higher than 30 ng/ml. Fasting glucose and insulin levels were significantly higher in subjects with vitamin D deficiency/insufficiency (P = 0.034 and P = 0.049, respectively) as well as HOMA-IR (P = 0.05). HDL cholesterol was significantly lower (P = 0.024) and intima-media thickness (IMT) higher (P = 0.014) in the vitamin D deficient/insufficient subjects. Moreover, serum 25(OH)D levels inversely correlated with insulin levels (P = 0.0001) and intima-media thickness (P = 0.015), and directly with serum HDL cholesterol (P = 0.010). At univariate regression analysis, the parameters that were significantly associated with vitamin D levels were insulin (P = 0.050), HDL cholesterol (P = 0.016), and intima-media thickness (P = 0.015). At multivariate analysis adjusted for age and BMI, vitamin D was still significantly associated with HDL cholesterol and intima-media thickness. CONCLUSIONS A positive association between vitamin D and HDL cholesterol was found in healthy women without any evidence of metabolic disorders, with a significant inverse correlation between vitamin D and IMT. These results suggest a possible protective role of 25(OH)D in cardiovascular disorders.
Collapse
Affiliation(s)
- S Giovinazzo
- Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Messina, AOU Policlinico "G. Martino" (Pad H, 4th Floor), Via Consolare Valeria, 1, 98125, Messina, Italy.
| | - A Alibrandi
- Department of Economics, Unit of Statistical and Mathematical Sciences, University of Messina, Messina, Italy
| | - A Campennì
- Department of Biomedical Sciences and Morpho-Functional Imaging, University of Messina, Messina, Italy
| | - F Trimarchi
- Accademia Peloritana dei Pericolanti, University of Messina, Messina, Italy
| | - R M Ruggeri
- Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Messina, AOU Policlinico "G. Martino" (Pad H, 4th Floor), Via Consolare Valeria, 1, 98125, Messina, Italy
| |
Collapse
|